Selected allogeneic dendritic cells markedly enhance human tumour antigen-specific T cell response in vitro

被引:0
作者
Alban Gervais
Jean-Christophe Eymard
Eric Toulmonde
Jacky Bernard
机构
[1] Unité de Thérapie Cellulaire,Institut Jean Godinot
[2] Etablissement Français du Sang,undefined
[3] Nord de France,undefined
来源
Cancer Immunology, Immunotherapy | 2009年 / 58卷
关键词
Alloreactivity; Dendritic cell; Antigen-specific T cell; Tumour-associated antigen; Adjuvant;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1831 / 1841
页数:10
相关论文
共 295 条
[1]  
Lesterhuis WJ(2008)Dendritic cell vaccines in melanoma: from promise to proof? Crit Rev Oncol Hematol 66 118-134
[2]  
Aarntzen EH(2001)The allogeneic response and tumor immunity Nat Med 7 649-652
[3]  
De Vries IJ(1969)The frequency of antigen-sensitive cells in tissue transplantation. A commentary on clonal selection J Exp Med 129 459-467
[4]  
Schuurhuis DH(2001)Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question J Immunol 166 973-981
[5]  
Figdor CG(1994)Cytokine interactions in human mixed lymphocyte culture Transplantation 57 1638-1642
[6]  
Adema GJ(1994)An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease J Exp Med 179 1155-1161
[7]  
Fabre JW(2003)Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections J Immunol 170 4077-4086
[8]  
Nisbet NW(2007)KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro J Immunol 179 854-868
[9]  
Simonsen M(2004)Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells Blood 104 170-177
[10]  
Zaleski M(2005)Human invariant NKT cells are required for effective in vitro alloresponses J Immunol 175 5087-5094